MarketBeat Instant News Alerts 2 hours agoDaVita (NYSE:DVA) Given "Hold (C+)" Rating at Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c+)" rating on shares of DaVita in a research note on Wednesday.NYSE:DVARead DaVita (NYSE:DVA) Given "Hold (C+)" Rating at Weiss Ratings2 hours agoDave (NASDAQ:DAVE) Receives Hold (C+) Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "hold (c+)" rating on shares of Dave in a research note on Wednesday.NASDAQ:DAVERead Dave (NASDAQ:DAVE) Receives Hold (C+) Rating from Weiss Ratings2 hours agoDave & Buster's Entertainment's (PLAY) "Sell (D)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reaffirmed a "sell (d)" rating on shares of Dave & Buster's Entertainment in a research note on Wednesday.NASDAQ:PLAYRead Dave & Buster's Entertainment's (PLAY) "Sell (D)" Rating Reiterated at Weiss Ratings2 hours agoDatadog (NASDAQ:DDOG) Earns Sell (D+) Rating from Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d+)" rating on shares of Datadog in a report on Wednesday.NASDAQ:DDOGRead Datadog (NASDAQ:DDOG) Earns Sell (D+) Rating from Weiss Ratings2 hours agoDarling Ingredients' (DAR) "Sell (D)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reissued a "sell (d)" rating on shares of Darling Ingredients in a research report on Wednesday.NYSE:DARRead Darling Ingredients' (DAR) "Sell (D)" Rating Reiterated at Weiss Ratings2 hours agoDarden Restaurants (NYSE:DRI) Receives Buy (B) Rating from Weiss RatingsMarketBeatWeiss Ratings reissued a "buy (b)" rating on shares of Darden Restaurants in a research report on Wednesday.NYSE:DRIRead Darden Restaurants (NYSE:DRI) Receives Buy (B) Rating from Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks Research2Quantum Computing Stocks To Keep An Eye On - October 7th3Zacks Research Issues Pessimistic Outlook for NIO Earnings4AST SpaceMobile, Inc. $ASTS Shares Sold by 111 Capital5IonQ (NYSE:IONQ) Shares Down 4.3% - Here's What Happened6Kraken Robotics (CVE:PNG) Sets New 12-Month High - What's Next?7MBL Wealth LLC Makes New $591,000 Investment in Solid Power, Inc. $SLDP8DraftKings (NASDAQ:DKNG) Shares Down 4.7% Following Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoDAQO New Energy (NYSE:DQ) Receives Sell (D) Rating from Weiss RatingsMarketBeatNYSE:DQRead DAQO New Energy (NYSE:DQ) Receives Sell (D) Rating from Weiss Ratings2 hours agoDanaos' (DAC) "Buy (B)" Rating Reiterated at Weiss RatingsMarketBeatNYSE:DACRead Danaos' (DAC) "Buy (B)" Rating Reiterated at Weiss Ratings2 hours agoDanaher (NYSE:DHR) Earns Hold (C-) Rating from Weiss RatingsMarketBeatNYSE:DHRRead Danaher (NYSE:DHR) Earns Hold (C-) Rating from Weiss Ratings2 hours agoDana's (DAN) Sell (D+) Rating Reiterated at Weiss RatingsMarketBeatNYSE:DANRead Dana's (DAN) Sell (D+) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates Hold (C-) Rating for Daktronics (NASDAQ:DAKT)MarketBeatNASDAQ:DAKTRead Weiss Ratings Reiterates Hold (C-) Rating for Daktronics (NASDAQ:DAKT)2 hours agoWeiss Ratings Reiterates Hold (C+) Rating for Daily Journal Corp. (S.C.) (NASDAQ:DJCO)MarketBeatNASDAQ:DJCORead Weiss Ratings Reiterates Hold (C+) Rating for Daily Journal Corp. (S.C.) (NASDAQ:DJCO)2 hours agoD.R. Horton (NYSE:DHI) Earns Hold (C+) Rating from Weiss RatingsMarketBeatNYSE:DHIRead D.R. Horton (NYSE:DHI) Earns Hold (C+) Rating from Weiss Ratings2 hours agoCytomX Therapeutics (NASDAQ:CTMX) Raised to "Hold (C-)" at Weiss RatingsMarketBeatNASDAQ:CTMXRead CytomX Therapeutics (NASDAQ:CTMX) Raised to "Hold (C-)" at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for Cytokinetics (NASDAQ:CYTK)MarketBeatNASDAQ:CYTKRead Weiss Ratings Reiterates "Sell (D-)" Rating for Cytokinetics (NASDAQ:CYTK)2 hours agoCytek Biosciences' (CTKB) "Sell (E+)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:CTKBRead Cytek Biosciences' (CTKB) "Sell (E+)" Rating Reiterated at Weiss Ratings2 hours agoLockheed Martin Corporation (NYSE:LMT) Plans Dividend Increase - $3.45 Per ShareMarketBeatNYSE:LMTRead Lockheed Martin Corporation (NYSE:LMT) Plans Dividend Increase - $3.45 Per Share2 hours agoWeiss Ratings Reaffirms Sell (D-) Rating for CVRx (NASDAQ:CVRX)MarketBeatNASDAQ:CVRXRead Weiss Ratings Reaffirms Sell (D-) Rating for CVRx (NASDAQ:CVRX)2 hours agoCVR Energy (NYSE:CVI) Earns Sell (D+) Rating from Weiss RatingsMarketBeatNYSE:CVIRead CVR Energy (NYSE:CVI) Earns Sell (D+) Rating from Weiss Ratings2 hours agoCustomers Bancorp (NYSE:CUBI) Receives "Hold (C)" Rating from Weiss RatingsMarketBeatNYSE:CUBIRead Customers Bancorp (NYSE:CUBI) Receives "Hold (C)" Rating from Weiss Ratings2 hours agoCustom Truck One Source (NYSE:CTOS) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNYSE:CTOSRead Custom Truck One Source (NYSE:CTOS) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoCushman & Wakefield's (CWK) Hold (C) Rating Reiterated at Weiss RatingsMarketBeatNYSE:CWKRead Cushman & Wakefield's (CWK) Hold (C) Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reaffirms Buy (B) Rating for Curtiss-Wright (NYSE:CW)MarketBeatNYSE:CWRead Weiss Ratings Reaffirms Buy (B) Rating for Curtiss-Wright (NYSE:CW)2 hours agoCurrenc Group's (CURR) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:CURRRead Currenc Group's (CURR) Sell (D-) Rating Reaffirmed at Weiss Ratings2 hours agoWeiss Ratings Reiterates Hold (C) Rating for CuriosityStream (NASDAQ:CURI)MarketBeatNASDAQ:CURIRead Weiss Ratings Reiterates Hold (C) Rating for CuriosityStream (NASDAQ:CURI)2 hours agoCureVac (NASDAQ:CVAC) Earns "Hold (C-)" Rating from Weiss RatingsMarketBeatNASDAQ:CVACRead CureVac (NASDAQ:CVAC) Earns "Hold (C-)" Rating from Weiss Ratings2 hours agoCurbline Properties (NYSE:CURB) Receives "Hold (C-)" Rating from Weiss RatingsMarketBeatNYSE:CURBRead Curbline Properties (NYSE:CURB) Receives "Hold (C-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (D-)" Rating for Cumberland Pharmaceuticals (NASDAQ:CPIX)MarketBeatNASDAQ:CPIXRead Weiss Ratings Reaffirms "Sell (D-)" Rating for Cumberland Pharmaceuticals (NASDAQ:CPIX)2 hours agoCulp's (CULP) "Sell (D-)" Rating Reaffirmed at Weiss RatingsMarketBeatNYSE:CULPRead Culp's (CULP) "Sell (D-)" Rating Reaffirmed at Weiss Ratings2 hours agoCubeSmart (NYSE:CUBE) Receives "Hold (C)" Rating from Weiss RatingsMarketBeatNYSE:CUBERead CubeSmart (NYSE:CUBE) Receives "Hold (C)" Rating from Weiss Ratings Featured Articles and OffersD-Wave Quantum (NYSE:QBTS) Downgraded to "Strong Sell" Rating by Zacks ResearchBy MarketBeat | October 8, 2025INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffFrom Traders Agency (Ad)3 Defense Stocks Surging as Ukraine Tensions DeepenBy Dan Schmidt | October 5, 2025Quantum Computing Stocks To Keep An Eye On - October 7thBy MarketBeat | October 9, 2025Is BigBear.ai the Next Palantir? By Gabriel Osorio-Mazilli | October 3, 2025Free: The Crypto Summit That Could Change Your LifeFrom Crypto 101 Media (Ad)When Downgrades Create Opportunities: 3 Stocks to Watch NowBy Thomas Hughes | October 7, 2025Why These 3 Tech Stocks Deserve Your Attention in Q4By Thomas Hughes | October 3, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
